Everhart Financial Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.78M | Buy |
16,584
+754
| +5% | +$81K | 0.21% | 66 |
|
|
2025
Q1 | $1.6M | Buy |
15,830
+722
| +5% | +$72.8K | 0.22% | 63 |
|
|
2024
Q4 | $1.35M | Buy |
15,108
+932
| +7% | +$83.2K | 0.28% | 65 |
|
|
2024
Q3 | $1.19M | Buy |
14,176
+1,412
| +11% | +$118K | 0.26% | 75 |
|
|
2024
Q2 | $983K | Buy |
12,764
+1,100
| +9% | +$84.7K | 0.26% | 76 |
|
|
2024
Q1 | $799K | Buy |
11,664
+4,093
| +54% | +$280K | 0.23% | 88 |
|
|
2023
Q4 | $438K | Buy |
7,571
+1,043
| +16% | +$60.3K | 0.16% | 133 |
|
|
2023
Q3 | $345K | Buy |
6,528
+1,219
| +23% | +$64.4K | 0.15% | 138 |
|
|
2023
Q2 | $287K | Buy |
5,309
+548
| +12% | +$29.6K | 0.12% | 164 |
|
|
2023
Q1 | $238K | Buy |
+4,761
| New | +$238K | 0.11% | 168 |
|
|
2022
Q4 | – | Sell |
-6,130
| Closed | -$238K | – | 190 |
|
|
2022
Q3 | $238K | Buy |
+6,130
| New | +$238K | 0.13% | 158 |
|